Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01448213 · ClinicalTrials.gov registry record · Phase 2
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
A Phase 2 study, sponsored by Price Vision Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 264
- Enrollment target
NCT01448213: Completed Phase 2 study, sponsored by Price Vision Group.
NCT01448213 is a Phase 2 study that has completed, run by Price Vision Group. The registered enrollment target is 264 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01448213, a Phase 2 study, has completed, sponsored by Price Vision Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 264 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two different commonly used steroid dosing regimens after Descemet's membrane endothelial keratoplasty (DMEK) transplant surgery. The investigators hope to determine if one is more effective at preventing rejection or if both are equally effective.
Interventions
- DRUG Prednisolone acetate
- DRUG Fluorometholone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
What the finished NCT01448213 record still lists
NCT01448213 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% higher).
The record links to 0 conditions, and to 2 interventions - of which Prednisolone acetate is the first listed.
NCT01448213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01448213 about?
NCT01448213 is a clinical study titled "Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)". The purpose of this study is to compare two different commonly used steroid dosing regimens after Descemet's membrane endothelial keratoplasty (DMEK) transplant surgery. The investigators hope to determine if one is more effective at preventing rejection or if both are equally effective.
What is the current status of trial NCT01448213?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 264 participants. The study started on 2011-10. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01448213?
The interventions under investigation include: Prednisolone acetate (DRUG), Fluorometholone (DRUG).
Who is sponsoring clinical trial NCT01448213?
This trial is sponsored by Price Vision Group, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01448213's enrollment target sits among peer trials
264 210th of 2000 higher than 1,791 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
- NCT04295863 · 264 participants · Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- NCT05220202 · 264 participants · NA
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
- NCT05473013 · 264 participants · NA
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia